Results 211 to 220 of about 355,709 (346)

CN4: ECONOMIC EVALUATION OF GEMZAR/CISPLATIN RELATIVE TO OTHER CISPLATIN BASED TREATMENTS FOR NON SMALL CELL LUNG (NSCLC) CANCER IN THE UK

, 2001
N. Botwood, J McKendrick, M Aristides, Miranda Lees, N Maniadakis, Wolfgang Wein, D. Stephenson   +6 more
openalex   +1 more source

1. Wertheimer Onkologie-Gespräch «Das nicht-kleinzellige Bronchialkarzinom (NSCLC) mit Taxotere^® frühzeitig wirksam behandeln» [PDF]

, 2003

openalex   +1 more source

Population-Based Outcomes in NSCLC [PDF]

JNCI Cancer Spectrum, 2019
openaire   +3 more sources

Interaction between IGF2BP3 and RP11-480I12.5 facilitates proliferation and suppresses apoptosis in non-small cell lung cancer. [PDF]

Eur J Med Res
Li R, Gao J, Chen H, Yi J, Yao Y, Liew FF, Li Y.   +6 more
europepmc   +1 more source

Oxidative phosphorylation at the crossroads of cancer: Metabolic orchestration, stromal collusion, and emerging therapeutic horizons

Interdisciplinary Medicine, EarlyView.
Although most cancer cells rely on aerobic glycolysis, Oxidative phosphorylation (OXPHOS) remains essential for their survival, proliferation, and metastasis. With the emergence of OXPHOS‐targeted drugs, its therapeutic potential is becoming increasingly evident.
Keke Chen, Bo Wang, Hongying Shu, Jianxin Lyu, Wei Cui, Hezhi Fang   +5 more
wiley   +1 more source

PCN9: ECONOMIC EVALUATION OF GEMZAR/CISPLATIN RELATIVE TO OTHER NEW AGENTS FOR NON SMALL CELL LUNG CANCER (NSCLC) IN THE UK

, 2001
Miranda Lees, M Aristides, N. Botwood, J McKendrick, N Maniadakis, Wolfgang Wein, D. Stephenson   +6 more
openalex   +1 more source

Leucine-rich repeat-containing G protein-coupled receptor 4 promotes proliferation, invasion and migration, and inhibits apoptosis in non-small cell lung cancer cells. [PDF]

Oncol Lett
Duan X, Liu X, Shan Y, Zhou S, Lou M, Gao Z, Yuan K.   +6 more
europepmc   +1 more source

Single‐cell RNA sequencing reveals the niche transitions in the non‐small cell lung cancer microenvironment mediated by piR‐hsa‐164586 during the invasive and metastatic processes

Interdisciplinary Medicine, EarlyView.
A novel mechanism of metastasis of non‐small cell lung cancer (NSCLC) involving piR‐hsa‐164586 was elucidated by single‐cell RNA sequencing. piR‐hsa‐164586 accelerates the invasion and metastasis of NSCLC by activating the PI3K‐AKT pathway and epithelial‐mesenchymal transition.
Yan Tang, Xiaomin Wang, Yanli Li, Kaibin Liu, Anjing Gong, Xin Ma, Jian Yuan, Yanhan Dong, Xiao Xu, Dan Han, Liang Zhang, Junlin Lv, Yiwei Xu, Zhen Shang, Nailong Pan, Xiaoying Kong, Wenhua Xu   +16 more
wiley   +1 more source

PCN6: MODELLING THE COST-EFFECTIVENESS OF DOCETAXEL IN THE SECOND LINE TREATMENT OF NON-SMALL-CELL LUNG CANCER (NSCLC)

, 2001
P Sharplin, UK Bose, Jordan A. Holmes
openalex   +1 more source

FXR shapes an immunosuppressive microenvironment in PD-L1lo/- non-small cell lung cancer by upregulating HVEM. [PDF]

JCI Insight
Xu X, Shang B, Wu H, Jin X, Wang J, Li J, Li D, Liang B, Wang X, Su L, You W, Jiang S.   +11 more
europepmc   +1 more source